GILLIS STEVEN
CIK 1229592
Transactions on file
32
Open-market buys
10
Win rate (buys)
25%
8 scored
Avg % since filing (buys)
-14.2%
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-11-03 | 2026-11-02 | ASPE Aspen Neuroscience, Inc. | Buy | 1,200,000 | $18.00M | -18.1% | open → | |
| 2026-11-03 | 2026-11-02 | ASPE Aspen Neuroscience, Inc. | C | 214,355 | $0.00 | — | open → | |
| 2026-11-03 | 2026-11-02 | ASPE Aspen Neuroscience, Inc. | C | 295,490 | $0.00 | — | open → | |
| 2026-11-03 | 2026-11-02 | ASPE Aspen Neuroscience, Inc. | C | 286,304 | $0.00 | — | open → | |
| 2026-11-03 | 2026-11-02 | ASPE Aspen Neuroscience, Inc. | C | 298,258 | $0.00 | — | open → | |
| 2026-11-03 | 2026-11-02 | ASPE Aspen Neuroscience, Inc. | Buy | 66,667 | $1.00M | -18.1% | open → | |
| 2026-11-03 | 2026-11-02 | ASPE Aspen Neuroscience, Inc. | C | 259,948 | $0.00 | — | open → | |
| 2026-11-03 | 2026-11-02 | ASPE Aspen Neuroscience, Inc. | C | 295,490 | $0.00 | — | open → | |
| 2026-11-03 | 2026-11-02 | ASPE Aspen Neuroscience, Inc. | C | 286,304 | $0.00 | — | open → | |
| 2026-11-03 | 2026-11-02 | ASPE Aspen Neuroscience, Inc. | C | 298,258 | $0.00 | — | open → | |
| 2026-11-03 | 2026-11-02 | ASPE Aspen Neuroscience, Inc. | C | 187,182 | $0.00 | — | open → | |
| 2026-11-03 | 2026-11-02 | ASPE Aspen Neuroscience, Inc. | Buy | 66,666 | $1000.0K | -18.1% | open → | |
| 2026-10-19 | 2026-10-19 | CTY CITY THERAPEUTICS, INC. | 10% | Buy | 170,000 | $3.06M | -8.8% | open → |
| 2026-10-19 | 2026-10-19 | CTY CITY THERAPEUTICS, INC. | 10% | C | 2,027,006 | $0.00 | — | open → |
| 2026-10-19 | 2026-10-19 | CTY CITY THERAPEUTICS, INC. | 10% | C | 5,482,309 | $0.00 | — | open → |
| 2026-10-19 | 2026-10-19 | CTY CITY THERAPEUTICS, INC. | 10% | C | 3,294,900 | $0.00 | — | open → |
| 2026-07-06 | 2026-07-01 | TAK TAKEDA PHARMACEUTICAL CO LTD | Director | Grant | 3,800 | $0.00 | — | open → |
| 2026-07-06 | 2026-07-01 | BOLD Boundless Bio, Inc. | 10% | Sale | 16,000 | $39.8K | -3.6% | open → |
| 2026-07-06 | 2026-07-01 | BOLD Boundless Bio, Inc. | 10% | Exer. | 16,000 | $16.5K | +133.0% | open → |
| 2026-06-24 | 2026-06-22 | KARD Kardigan, Inc. | Director10% | Buy | 1,250,000 | $20.00M | -11.7% | open → |
| 2026-06-22 | 2026-06-17 | KARD Kardigan, Inc. | C | 13,792,035 | $0.00 | — | open → | |
| 2025-02-03 | 2025-02-03 | MTSR Metsera, Inc. | 10% | C | 7,523,682 | — | — | open → |
| 2025-02-03 | 2025-02-03 | MTSR Metsera, Inc. | 10% | Buy | 1,432,224 | $25.78M | — | open → |
| 2025-02-03 | 2025-02-03 | MTSR Metsera, Inc. | 10% | Buy | 789,998 | $14.22M | — | open → |
| 2025-02-03 | 2025-02-03 | MTSR Metsera, Inc. | 10% | C | 16,006,949 | — | — | open → |
| 2026-05-04 | 2026-05-04 | SPTX Seaport Therapeutics, Inc. | Buy | 1,100,000 | $19.80M | +12.2% | open → | |
| 2026-05-04 | 2026-05-04 | SPTX Seaport Therapeutics, Inc. | C | 2,681,265 | $0.00 | — | open → | |
| 2026-05-04 | 2026-05-04 | SPTX Seaport Therapeutics, Inc. | C | 2,513,686 | $0.00 | — | open → | |
| 2025-11-14 | 2025-11-13 | MTSR Metsera, Inc. | Director10% | Disp. | 8,313,680 | $0.00 | — | open → |
| 2025-11-14 | 2025-11-13 | MTSR Metsera, Inc. | Director10% | Disp. | 18,503,128 | $0.00 | — | open → |
| 2025-10-29 | 2025-10-27 | NMRA Neumora Therapeutics, Inc. | 10% | Buy | 1,915,700 | $5.00M | -72.0% | open → |
| 2025-08-01 | 2025-08-01 | PRME Prime Medicine, Inc. | 10% | Buy | 3,030,300 | $10.00M | +20.9% | open → |
